BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1698309)

  • 1. Monocyte function in IDDM patients and healthy individuals.
    Mølvig J; Pociot F; Baek L; Worsaae H; Dall Wogensen L; Christensen P; Staub-Nielsen L; Mandrup-Poulsen T; Manogue K; Nerup J
    Scand J Immunol; 1990 Sep; 32(3):297-311. PubMed ID: 1698309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus.
    Pociot F; Mølvig J; Wogensen L; Worsaae H; Dalbøge H; Baek L; Nerup J
    Scand J Immunol; 1991 Jan; 33(1):37-49. PubMed ID: 1996407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endotoxin-stimulated human monocyte secretion of interleukin 1, tumour necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences.
    Mølvig J; Baek L; Christensen P; Manogue KR; Vlassara H; Platz P; Nielsen LS; Svejgaard A; Nerup J
    Scand J Immunol; 1988 Jun; 27(6):705-16. PubMed ID: 3260683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary supplementation with omega-3-polyunsaturated fatty acids decreases mononuclear cell proliferation and interleukin-1 beta content but not monokine secretion in healthy and insulin-dependent diabetic individuals.
    Mølvig J; Pociot F; Worsaae H; Wogensen LD; Baek L; Christensen P; Mandrup-Poulsen T; Andersen K; Madsen P; Dyerberg J
    Scand J Immunol; 1991 Oct; 34(4):399-410. PubMed ID: 1656517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of class II MHC molecules in the LPS-induction of IL-1/TNF secretions by human monocytes. Quantitative differences at the polymorphic level.
    Santamaria P; Gehrz RC; Bryan MK; Barbosa JJ
    J Immunol; 1989 Aug; 143(3):913-22. PubMed ID: 2787351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro.
    Pociot F; Mølvig J; Wogensen L; Worsaae H; Nerup J
    Eur J Clin Invest; 1992 Jun; 22(6):396-402. PubMed ID: 1353022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus.
    Pociot F; Briant L; Jongeneel CV; Mölvig J; Worsaae H; Abbal M; Thomsen M; Nerup J; Cambon-Thomsen A
    Eur J Immunol; 1993 Jan; 23(1):224-31. PubMed ID: 8093442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor-beta gene RFLP alleles in Finnish IDDM haplotypes. The Childhood Diabetes in Finland (DiMe) Study Group.
    Ilonen J; Merivuori H; Reijonen H; Knip M; Akerblom HK; Pociot F; Nerup J
    Scand J Immunol; 1992 Dec; 36(6):779-83. PubMed ID: 1361076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PGE2, IL-1 beta, and TNF-alpha responses in diabetics as modifiers of periodontal disease expression.
    Salvi GE; Beck JD; Offenbacher S
    Ann Periodontol; 1998 Jul; 3(1):40-50. PubMed ID: 9722689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of TNF*B gene polymorphism on TNF-alpha and -beta secretion levels in patients with insulin-dependent diabetes mellitus and healthy controls.
    Whichelow CE; Hitman GA; Raafat I; Bottazzo GF; Sachs JA
    Eur J Immunogenet; 1996 Dec; 23(6):425-35. PubMed ID: 8971540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-alpha gene polymorphisms: association with type I (insulin-dependent) diabetes mellitus.
    Badenhoop K; Schwarz G; Bingley P; Trowsdale J; Usadel KH; Gale EA; Bottazzo GF
    J Immunogenet; 1989 Dec; 16(6):455-60. PubMed ID: 2577113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-alpha gene polymorphisms in type 1 (insulin-dependent) diabetes mellitus.
    Badenhoop K; Schwarz G; Trowsdale J; Lewis V; Usadel KH; Gale EA; Bottazzo GF
    Diabetologia; 1989 Jul; 32(7):445-8. PubMed ID: 2572498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between HLA-DR2 and production of tumour necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide.
    Bendtzen K; Morling N; Fomsgaard A; Svenson M; Jakobsen B; Odum N; Svejgaard A
    Scand J Immunol; 1988 Nov; 28(5):599-606. PubMed ID: 3264932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control by IFN-gamma and PGE2 of TNF alpha and IL-1 production by human monocytes.
    Hart PH; Whitty GA; Piccoli DS; Hamilton JA
    Immunology; 1989 Mar; 66(3):376-83. PubMed ID: 2495247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 1 beta, tumour necrosis factor-alpha and interleukin 1 receptor antagonist in newly diagnosed insulin-dependent diabetes mellitus: comparison to long-standing diabetes and healthy individuals.
    Netea MG; Hancu N; Blok WL; Grigorescu-Sido P; Popa L; Popa V; van der Meer JW
    Cytokine; 1997 Apr; 9(4):284-7. PubMed ID: 9112337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in insulin-dependent diabetes mellitus.
    Ohno Y; Aoki N; Nishimura A
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1072-7. PubMed ID: 8408455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of the genetic associations of HLA-DR3 and tumour necrosis factor alpha with human IDDM.
    Cox A; Gonzalez AM; Wilson AG; Wilson RM; Ward JD; Artlett CM; Welsh K; Duff GW
    Diabetologia; 1994 May; 37(5):500-3. PubMed ID: 8056188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of HLA-DR phenotypes and T-lymphocyte-receptor beta-chain-region RFLP with IDDM in Japanese.
    Ito M; Tanimoto M; Kamura H; Yoneda M; Morishima Y; Takatsuki K; Itatsu T; Saito H
    Diabetes; 1988 Dec; 37(12):1633-6. PubMed ID: 2903835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-dependent diabetes mellitus: HLA-DR and -DQ genotyping in three ethnic groups.
    Kohonen-Corish MR; Serjeantson SW; Lee HK; Zimmet P
    Dis Markers; 1987 Sep; 5(3):153-64. PubMed ID: 2901933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of PPD-specific T-cell lines generated in type I (insulin-dependent) diabetic and healthy individuals.
    Mølvig J; Sønderstrup McDevitt G; Thomsen M; Bosmann B; Blangero C; de Preval C; Baek L; Nerup J
    Scand J Immunol; 1989 Nov; 30(5):615-29. PubMed ID: 2587937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.